Eli Lilly Analysts Recommendations and Consensus

LLY -- USA Stock  

Fiscal Quarter End: December 31, 2019  

The current analyst and expert consensus on Eli Lilly is Buy with 0 strong sell and 6 strong buy opinions. The current projected target price consensus is 134.71 with 7 analysts opinions. The most common way Eli Lilly And analysts use to provide recommendation to public is financial statements analysis. Many experts also interview Eli Lilly executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Eli Lilly. We strongly encourage you to use your own analysis of Eli Lilly And to validate this buy or sell advice. Eli Lilly buy or sell recommendation module provides average expert sentiment on the projected Eli Lilly And target price to derive its highest and lowest estimates based on projected price volatility of 9.673. Please see also Macroaxis Advice on Eli Lilly to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

Eli Lilly Target Price Consensus

Number of Opinions9
Lowered Outlook0
Raized Outlook0
Buy
Macroaxis Recommendation   Exposure   Valuation

Eli Lilly Target Price Projection

Current Price

Eli Lilly Market Quote

Low Price113.39Odds
High Price113.98Odds

113.39

Target Price

Analyst Consensus On Target Price

Low Estimate116.0Odds
High Estimate145.0Odds
Number of Analysts7
Standard Deviation9.673

134.714

Eli Lilly Analysit Ratings

Average Consensus

Search macroaxis.com